From microscopes to a billion-dollar corruption scandal: the turbulent history of Olympus Corporation.
Founded in 1919 to manufacture microscopes, Olympus became a global titan in medical imaging. Yet, its legacy is split between technological innovation and one of the most notorious corporate fraud cases in history, where executives hid over a billion dollars in losses for decades while silencing whistleblowers.
Olympus began as Takachiho Seisakusho in 1919, eventually pivoting from thermometers and microscopes to become a dominant force in optics. By the 21st century, it secured a 70 percent share of the global endoscope market. However, the company's trajectory shifted dramatically in 2011 when it fired its newly appointed CEO, Michael Christopher Woodford. Woodford, a 30-year veteran, had raised alarms about suspicious payments tied to acquisitions, including a record-breaking 31 percent success fee paid to a middleman during the 2008 Gyrus Group purchase.
The ensuing investigation revealed that Olympus had been concealing over ¥117.7 billion in investment losses since the 1990s. This elaborate cover-up, which involved kickbacks and payments to criminal organizations, triggered a massive collapse in the company's valuation and led to the arrests of multiple executives, including former president Tsuyoshi Kikukawa. In 2016, the firm paid $646 million in fines to US authorities to resolve the fallout from this long-running scheme.
Governance issues persisted long after the 2011 scandal. In 2024, the company faced further turmoil when CEO Stefan Kaufmann was forced to resign following allegations of illegal drug use and extortion. Investigations revealed Kaufmann had paid 9,150,000 yen in hush money to a dealer, leading to a prison sentence. Today, Olympus has divested from its historic camera and scientific imaging divisions, focusing exclusively on surgical technologies and medical devices to navigate its future.
Source: Olympus Corporation
